Laboratorio Reig Jofre, S.A. (BME:RJF)
Spain · Delayed Price · Currency is EUR 2.410
+0.060 (2.55%)
At close: Mar 18, 2026
Laboratorio Reig Jofre Market Cap
Laboratorio Reig Jofre has a market cap or net worth of €196.2 million as of March 18, 2026. Its market cap has decreased by -5.74% in one year.
Market Cap
196.20M
Enterprise Value
274.62M
Revenue
336.68M
Ranking
n/a
PE Ratio
40.17
Stock Price
€2.41
Market Cap Chart
Since March 2, 2015, Laboratorio Reig Jofre's market cap has decreased from 398.12M to 196.20M, a decrease of -50.72%. That is a compound annual growth rate of -6.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 196.20M | -6.20% |
| Dec 31, 2025 | 209.17M | 4.93% |
| Dec 31, 2024 | 199.35M | 12.43% |
| Dec 29, 2023 | 177.31M | 4.21% |
| Dec 30, 2022 | 170.15M | -32.16% |
| Dec 30, 2021 | 250.81M | -25.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.66B |
| Laboratorios Farmaceuticos Rovi | 4.08B |
| Almirall | 2.47B |
| Pharma Mar | 1.44B |
| Clínica Baviera | 804.13M |
| Atrys Health | 223.07M |
| Oryzon Genomics | 219.75M |
| Prim, S.A. | 211.85M |